Search For "pharmaceutical"
Preventive healthcare is more than important in current times
Updated : 5 years, 9 months ago IST
New Delhi [India] June 19 (ANI/Mediawire): The only thing constant in this world is "Change". Keeping that in mind KOPRAN Pharmaceutical is evolving in tune with changing times; Kopran is refocusing to meet newly raised great demands of the preventive healthcare industry.
Read More
Cipla expands partnership with Roche Pharma to improve access for oncology
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 18 (ANI): Pharmaceutical majors Cipla and Roche Products India said on Thursday they have entered into an agreement to provide better access to innovative medicines for patients in India.
Read More
Cipla to acquire 21.85 pc stake in GoApptiv, expand reach in small towns
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 10 (ANI): Pharmaceutical major Cipla said on Wednesday it will acquire 21.85 per cent stake in GoApptiv to expand the reach of its key brands in tier three plus towns.
Read More
A2A Pharmaceuticals collaborates with LAXAI Life Sciences to Co-develop SA
Updated : 5 years, 9 months ago IST
Hyderabad (Telangana) [India], June 9 (ANI/PRNewswire): A2A Pharmaceuticals, a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents announces today an agreement to co-develop SARS-CoV-2 Main Proteases inhibitors for the treatment of
Read More
Sun Pharma initiates phase two clinical trial on AQCH as potential treatme
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
Piyush Goyal interacts with pharma industry captains
Updated : 5 years, 10 months ago IST
New Delhi [India], May 31 (ANI): Commerce and Industry Minister Piyush Goyal on Sunday held an interaction with the captains of the pharmaceutical industry companies and office-bearers of the Pharma associations through the video conference.
Read More
Piyush Goyal interacts with pharmaceutical industry stakeholders, addresse
Updated : 5 years, 10 months ago IST
New Delhi [India], May 31 (ANI): Industry and Commerce, and Railway Minister Piyush Goyal on Sunday interacted with stakeholders from the pharmaceutical industry and addressed the issues faced by them in the wake of COVID-19.
Read More
Sun Pharma gets DCGI approval for clinical trial with Nafamostat in Covid-
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
Read More
Centre removes restrictions on exports of paracetamol APIs
Updated : 5 years, 10 months ago IST
New Delhi [India], May 29 (ANI): The Central government on Thursday removed restrictions on the export of paracetamol APIs (active pharmaceutical ingredients) making it export free.
Read More
Pharmacy and Biotechnology students of Chandigarh University gets placed i
Updated : 5 years, 10 months ago IST
Chandigarh [India], May 26 (ANI/PRNewswire): With India ranking third globally in the production of medicines and largest producer of generic medicines, the pharmaceutical sector of the country has grown in leaps and bounds during the last two decades.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More